Cosmo Feilding Mellen
Directeur Général chez Beckley Canopy Therapeutics Ltd.
Profil
Cosmo Feilding Mellen has founded Beckley Psytech Ltd.
in 1998, where he currently holds the title of Chief Executive Officer & Director.
He is also currently working as Co-Managing-Director & Director at Beckley Canopy Therapeutics Ltd.
Postes actifs de Cosmo Feilding Mellen
| Sociétés | Poste | Début |
|---|---|---|
Beckley Canopy Therapeutics Ltd.
 Beckley Canopy Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Beckley Canopy Therapeutics Ltd. operates as a biopharmaceutical company. It researches and develops innovative cannabis-based health products. The company was founded on January 19, 2018 and is headquartered in Oxford, the United Kingdom. | Directeur Général | - |
Beckley Psytech Ltd.
 Beckley Psytech Ltd. Pharmaceuticals: MajorHealth Technology Beckley Psytech Ltd. operates as a psychedelic medicine company. It engages in helping patients suffering from neurological and mental health disorders by developing psychedelic compounds. The company was founded by Lady Amanda Feilding and Cosmo Feilding Mellen in 1998 and is headquartered in the United Kingdom. | Fondateur | 01/01/1998 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Beckley Canopy Therapeutics Ltd.
Beckley Canopy Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Beckley Canopy Therapeutics Ltd. operates as a biopharmaceutical company. It researches and develops innovative cannabis-based health products. The company was founded on January 19, 2018 and is headquartered in Oxford, the United Kingdom. | Commercial Services |
Beckley Psytech Ltd.
Beckley Psytech Ltd. Pharmaceuticals: MajorHealth Technology Beckley Psytech Ltd. operates as a psychedelic medicine company. It engages in helping patients suffering from neurological and mental health disorders by developing psychedelic compounds. The company was founded by Lady Amanda Feilding and Cosmo Feilding Mellen in 1998 and is headquartered in the United Kingdom. | Health Technology |